Cargando…

Hyperuricemia and chronic kidney disease: to treat or not to treat

Hyperuricemia is common in chronic kidney disease (CKD) and may be present in 50% of patients presenting for dialysis. Hyperuricemia can be secondary to impaired glomerular filtration rate (GFR) that occurs in CKD. However, hyperuricemia can also precede the development of kidney disease and predict...

Descripción completa

Detalles Bibliográficos
Autores principales:	Piani, Federica, Sasai, Fumihiko, Bjornstad, Petter, Borghi, Claudio, Yoshimura, Ashio, Sanchez-Lozada, Laura G., Roncal-Jimenez, Carlos, Garcia, Gabriela E., Hernando, Ana Andres, Fuentes, Gabriel Cara, Rodriguez-Iturbe, Bernardo, Lanaspa, Miguel A, Johnson, Richard J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sociedade Brasileira de Nefrologia 2021
Materias:	Update Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8940113/ https://www.ncbi.nlm.nih.gov/pubmed/33704350 http://dx.doi.org/10.1590/2175-8239-JBN-2020-U002

Ejemplares similares

Endogenous Fructose Metabolism Could Explain the Warburg Effect and the Protection of SGLT2 Inhibitors in Chronic Kidney Disease
por: Nakagawa, Takahiko, et al.
Publicado: (2021)

Acute Kidney Injury in Pediatric Diabetic Kidney Disease
por: Piani, Federica, et al.
Publicado: (2021)

Uric Acid and Chronic Kidney Disease: Still More to Do
por: Johnson, Richard J., et al.
Publicado: (2022)

The Optimal Range of Serum Uric Acid for Cardiometabolic Diseases: A 5-Year Japanese Cohort Study †
por: Kuwabara, Masanari, et al.
Publicado: (2020)

Hyperosmolarity and Increased Serum Sodium Concentration Are Risks for Developing Hypertension Regardless of Salt Intake: A Five-Year Cohort Study in Japan †
por: Kuwabara, Masanari, et al.
Publicado: (2020)

Increased Serum Sodium and Serum Osmolarity Are Independent Risk Factors for Developing Chronic Kidney Disease; 5 Year Cohort Study
por: Kuwabara, Masanari, et al.
Publicado: (2017)

Correction: Increased Serum Sodium and Serum Osmolarity Are Independent Risk Factors for Developing Chronic Kidney Disease; 5 Year Cohort Study
por: Kuwabara, Masanari, et al.
Publicado: (2018)

Vasopressin mediates fructose-induced metabolic syndrome by activating the V1b receptor
por: Andres-Hernando, Ana, et al.
Publicado: (2021)

Hyperuricemia, the heart, and the kidneys – to treat or not to treat?
por: Petreski, Tadej, et al.
Publicado: (2020)

A randomised placebo controlled trial of anakinra for treating pustular psoriasis: statistical analysis plan for stage two of the APRICOT trial
por: Cro, Suzie, et al.
Publicado: (2020)

The fructose survival hypothesis for obesity
por: Johnson, Richard J., et al.
Publicado: (2023)

Investigating the effectiveness and cost-effectiveness of FITNET-NHS (Fatigue In Teenagers on the interNET in the NHS) compared to activity management to treat paediatric chronic fatigue syndrome (CFS)/myalgic encephalomyelitis (ME): amendment to the published protocol
por: Anderson, Emma, et al.
Publicado: (2019)

To treat or not to treat asymptomatic hyperuricemia in chronic kidney disease
por: Shin, Dong Ho
Publicado: (2019)

‘Test n Treat (TnT)’: a cluster-randomised feasibility trial of frequent, rapid-testing and same-day, on-site treatment to reduce rates of chlamydia in high-risk further education college students: statistical analysis plan
por: Phillips, Rachel, et al.
Publicado: (2018)

The role of the surgeon in treating patients with lung cancer. An updating article
por: Pêgo-Fernandes, Paulo Manuel, et al.
Publicado: (2021)

A Novel Treatment for Glomerular Disease: Targeting the Activated Macrophage Folate Receptor with a Trojan Horse Therapy in Rats
por: Garcia, Gabriela E., et al.
Publicado: (2021)

Prevention of Renal Damage by Treating Hyperuricemia
por: Nickavar, Azar
Publicado: (2013)

Development of Systemic and Topical Drugs to Treat Non-muscle Invasive Bladder Cancer
por: Jarow, Jonathan, et al.
Publicado: (2015)

Call to action: treating dry eye disease and setting the foundation for successful surgery
por: Donaldson, Kendall, et al.
Publicado: (2022)

Uric Acid Stimulates Fructokinase and Accelerates Fructose Metabolism in the Development of Fatty Liver
por: Lanaspa, Miguel A., et al.
Publicado: (2012)

Reporting quality of clinical practice guidelines regarding gout and hyperuricemia according to the RIGHT checklist: systematic review
por: Wang, Can, et al.
Publicado: (2021)

Different Risk for Hypertension, Diabetes, Dyslipidemia, and Hyperuricemia According to Level of Body Mass Index in Japanese and American Subjects
por: Kuwabara, Masanari, et al.
Publicado: (2018)

Diagnostic and Prognostic Role of CD93 in Cardiovascular Disease: A Systematic Review
por: Piani, Federica, et al.
Publicado: (2023)

Comment on: Prevention of Renal Damage by Treating Hyperuricemia
por: Nasri, Hamid, et al.
Publicado: (2015)

THE IMPORTANCE OF THE DIAGNOSIS OF SUBCHONDRAL FRACTURE OF THE FEMORAL HEAD, HOW TO DIFFERENTIATE IT FROM AVASCULAR NECROSIS AND HOW TO TREAT IT
por: Polesello, Giancarlo, et al.
Publicado: (2015)

Preventing and treating medication overuse headache
por: Alstadhaug, Karl B., et al.
Publicado: (2017)

Evidence-based interventions to treat chronic low back pain: treatment selection for a personalized medicine approach
por: Mauck, Matthew C., et al.
Publicado: (2022)

Rehydration with fructose worsens dehydration-induced renal damage
por: Milagres, Tamara, et al.
Publicado: (2018)

Keeping up with the guidelines: design changes to the STREAM stage 2 randomised controlled non-inferiority trial for rifampicin-resistant tuberculosis
por: Goodall, Ruth L., et al.
Publicado: (2022)

Electro-acupuncture at Conception and Governor vessels and transplantation of umbilical cord blood-derived mesenchymal stem cells for treating cerebral ischemia/reperfusion injury
por: Yu, Haibo, et al.
Publicado: (2014)

The Promotoer, a brain-computer interface-assisted intervention to promote upper limb functional motor recovery after stroke: a statistical analysis plan for a randomized controlled trial
por: Cipriani, Marta, et al.
Publicado: (2023)

Counteracting Roles of AMP Deaminase and AMP Kinase in the Development of Fatty Liver
por: Lanaspa, Miguel A., et al.
Publicado: (2012)

Minimal Change Disease Is Associated With Endothelial Glycocalyx Degradation and Endothelial Activation
por: Bauer, Colin, et al.
Publicado: (2021)

Renal Oxidative Stress Induced by Long-Term Hyperuricemia Alters Mitochondrial Function and Maintains Systemic Hypertension
por: Cristóbal-García, Magdalena, et al.
Publicado: (2015)

Editorial Comment: Increased risk of dementia among patients with overactive bladder treated with an anticholinergic medication compared to a beta-3 agonist: a population-based cohort study
por: Moreno-Palacios, Jorge
Publicado: (2021)

Treating Hyperuricemia: The Last Word Hasn’t Been Said Yet
por: Russo, Elisa, et al.
Publicado: (2021)

Psoriatic arthritis with hyperuricemia: more peripheral, destructive, and challenging to treat
por: Widawski, L., et al.
Publicado: (2022)

Statistical analysis plan for a cluster-randomised trial assessing the effectiveness of implementation of a bedside evidence-based checklist for clinical management of brain-dead potential organ donors in intensive care units: DONORS (Donation Network to Optimise Organ Recovery Study)
por: Giordani, Natalia Elis, et al.
Publicado: (2020)

Therapeutic Strategies for the Treatment of Chronic Hyperuricemia: An Evidence-Based Update
por: Cicero, Arrigo F. G., et al.
Publicado: (2021)

Alleviation of Hyperuricemia by Strictinin in AML12 Mouse Hepatocytes Treated with Xanthine and in Mice Treated with Potassium Oxonate
por: Huang, Kuo-Ching, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ttontl6d1e11kcpc9s4ptmcljj